A day that will live in infamy: U.S. crosses 500,000th COVID-19 death The United States on Monday crossed the staggering milestone of 500,000 COVID-19 deaths just over a year since the coronavirus pandemic claimed its first known victim in Santa Clara County, California. Maria Caspani, Anurag Maan U.S.

NEW YORK (Reuters) - The United States on Monday crossed the staggering milestone of 500,000 COVID-19 deaths just over a year since the coronavirus pandemic claimed its first known victim in Santa Clara County, California.

US coronavirus death toll approaches milestone of 500,000 The U.S. stood Sunday at the brink of a once-unthinkable tally: 500,000 people lost to the coronavirus. A year into the pandemic, the running total of lives lost was about 498,000 — roughly... AP NEWS

The U.S. stood at the brink of a once-unthinkable tally: 500,000 people lost to the coronavirus.

Breaking down the psychology of vaccine hesitancy Identifying the psychological barriers to taking vaccines is key to reaching the vaccine-hesitant. Bryan Walsh Axios

A new survey identifies some of the psychological barriers to taking vaccines — and how to overcome them.

The big picture: With COVID vaccine production and distribution ramping up, we're going to reach a moment when supply exceeds demand, which puts a premium on finding ways to persuade the persuadable on the value of vaccines.

America's vaccine rollout has been among the best in the world It hasn't been perfect. It could be a whole lot worse. Dave Lawler Axios

America’s much-maligned vaccine rollout is actually going relatively well, at least compared to other wealthy countries.

A Third of COVID Survivors Have Long-Haul Symptoms Months after illness clears, many say symptoms like fatigue, loss of smell or taste and "brain fog" persist. WebMD

(HealthDay News) -- Many patients with mild to moderate COVID-19 could become "long haulers," suffering symptoms months after they clear their non-life-threatening infection, new research shows.

COVID-19 Vaccine Tracker, Distribution Maps and FAQ A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Time

Since Dec. 14, 2020, when an intensive care nurse in New York became the first American to receive an injection of a COVID-19 vaccine, the U.S. has allotted 55.6 million initial doses of two cutting-edge inoculations, from Pfizer-BioNTech and Moderna, that represent the greatest hope for closure to a pandemic that has claimed 2 million lives worldwide, including nearly 496,000 Americans—by far the largest toll of any nation.